Drug-Drug Interaction Study Between EDP-938, Tacrolimus, Dabigatran, Rosuvastatin and Midazolam in Healthy Subjects
Status:
Completed
Trial end date:
2021-06-01
Target enrollment:
Participant gender:
Summary
A Non-Randomized, Open-Label, Three-Part, Drug-Drug Interaction Study to Evaluate the Effects
of tacrolimus, dabigatran, rosuvastatin and midazolam on the Pharmacokinetics and Safety of
EDP-938 in Healthy Subjects